CARE Ratings Limited (BOM:534804)
India · Delayed Price · Currency is INR 1,658.55
+38.20 (2.36%)
At close: Oct 30, 2026
CARE Ratings Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 5,186 | 4,731 | 4,023 | 3,317 | 2,790 | 2,476 |
Other Revenue | 41.09 | - | - | - | - | - |
| 5,227 | 4,731 | 4,023 | 3,317 | 2,790 | 2,476 | |
Revenue Growth | 19.80% | 17.59% | 21.30% | 18.89% | 12.66% | -0.33% |
Cost of Revenue | 2,296 | 2,166 | 1,913 | 1,646 | 1,339 | 1,264 |
Gross Profit | 2,932 | 2,565 | 2,110 | 1,671 | 1,450 | 1,212 |
Selling, General & Admin | 47.07 | 47.07 | 31.61 | - | - | - |
Other Operating Expenses | 634.2 | 537.84 | 517.13 | 549.67 | 400.02 | 413.99 |
Operating Expenses | 839.47 | 734.48 | 673.68 | 654.5 | 505.31 | 491.05 |
Operating Income | 2,092 | 1,830 | 1,436 | 1,017 | 945.18 | 721.16 |
Interest Expense | -24.52 | -24.86 | -21.08 | -17.12 | -10.02 | -4.64 |
Interest & Investment Income | 488.34 | 488.34 | 457.05 | 428.95 | 353.66 | 254.82 |
Currency Exchange Gain (Loss) | 11.65 | 11.65 | 2.21 | 1.59 | 11.17 | - |
Other Non Operating Income (Expenses) | 11.94 | 11.94 | 4.22 | 9.94 | 8.44 | 11.19 |
EBT Excluding Unusual Items | 2,580 | 2,317 | 1,879 | 1,440 | 1,308 | 982.53 |
Gain (Loss) on Sale of Investments | 33.95 | 33.95 | 44.06 | 26.43 | 6.1 | 5.9 |
Asset Writedown | - | - | - | - | -57.06 | -2.13 |
Other Unusual Items | 2.28 | 2.28 | - | - | - | - |
Pretax Income | 2,616 | 2,354 | 1,923 | 1,466 | 1,257 | 986.3 |
Income Tax Expense | 662.28 | 616.58 | 522.64 | 440.66 | 402.89 | 218.01 |
Earnings From Continuing Operations | 1,953 | 1,737 | 1,400 | 1,026 | 854.58 | 768.29 |
Minority Interest in Earnings | -25.11 | -25.19 | -27.63 | -20.39 | -19.29 | -17.21 |
Net Income | 1,928 | 1,712 | 1,372 | 1,005 | 835.29 | 751.08 |
Net Income to Common | 1,928 | 1,712 | 1,372 | 1,005 | 835.29 | 751.08 |
Net Income Growth | 26.15% | 24.73% | 36.52% | 20.35% | 11.21% | -16.10% |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Change | 0.15% | 0.27% | 0.61% | 0.68% | -0.06% | 0.56% |
EPS (Basic) | 64.16 | 57.06 | 45.89 | 33.77 | 28.17 | 25.45 |
EPS (Diluted) | 63.97 | 56.83 | 45.69 | 33.67 | 28.17 | 25.31 |
EPS Growth | 25.95% | 24.38% | 35.70% | 19.54% | 11.29% | -16.55% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,618 | 1,393 | 1,082 | 817.1 | 707.36 | 490.2 |
Free Cash Flow Per Share | 53.67 | 46.24 | 36.02 | 27.37 | 23.85 | 16.52 |
Dividend Per Share | 14.000 | 22.000 | 18.000 | 18.000 | 17.000 | 17.000 |
Dividend Growth | -26.32% | 22.22% | 0% | 5.88% | 0% | 0% |
Gross Margin | 56.08% | 54.21% | 52.44% | 50.38% | 51.99% | 48.95% |
Operating Margin | 40.02% | 38.69% | 35.70% | 30.65% | 33.88% | 29.12% |
Profit Margin | 36.89% | 36.18% | 34.11% | 30.31% | 29.94% | 30.33% |
Free Cash Flow Margin | 30.95% | 29.44% | 26.90% | 24.64% | 25.35% | 19.79% |
EBITDA | 2,169 | 1,899 | 1,500 | 1,081 | 1,004 | 761.21 |
EBITDA Margin | 41.50% | 40.14% | 37.28% | 32.58% | 35.97% | 30.74% |
D&A For EBITDA | 77.35 | 68.72 | 63.75 | 63.99 | 58.42 | 40.05 |
EBIT | 2,092 | 1,830 | 1,436 | 1,017 | 945.18 | 721.16 |
EBIT Margin | 40.02% | 38.69% | 35.70% | 30.65% | 33.88% | 29.12% |
Effective Tax Rate | 25.32% | 26.20% | 27.18% | 30.05% | 32.04% | 22.10% |
Revenue as Reported | 5,775 | 5,279 | 4,531 | 3,784 | 3,169 | 2,748 |